越南肺癌的结果:一项6年的回顾性研究
Khanh Toan Nguyen1, Thi Huong Pham1,2, Van Lam Ngo1
1Nghe An Oncology Hospital, Vinh, Nghe An Province, Vietnam.
Journal of immunotherapy and precision oncology
|December 8, 2025
概括
越南的肺癌存活率随着早期诊断和个性化治疗的增加而有所改善. 影响死亡率的关键因素包括晚期,男性性别和非手术初始治疗.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 肺癌仍然是全球和越南的重大健康挑战.
- 了解患者人口统计,治疗模式和生存率对于改善护理至关重要.
研究的目的:
- 记录越南肺癌患者的患者特征,治疗方法和生存结果.
- 分析六年 (2018-2024) 的诊断和治疗趋势.
主要方法:
- 在恩赫安瘤医院对3548名肺癌患者 (2018-2024) 的回顾性研究.
- 主要终点:非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的治疗方法,以及整体存活率 (OS).
- 二级终点:影响生存时间的因素.
主要成果:
- 无小细胞癌占病例的87%,其中腺癌是最常见的亚型 (67%).
- 早期诊断率从2.7%增加到9%,而晚期诊断率则下降.
- 平均寿命为15.3个月;5年生存率为14.2%. 第四期NSCLC的5年生存率为8.3%.
- 独立的死亡因素包括男性性别,表现不佳状态,小细胞组织学和转移性疾病.
结论:
- 个性化治疗方法对于改善越南肺癌结果至关重要.
- 迫切需要加强早期检测和获得先进疗法,以减少肺癌负担.
- 调查结果突出了对肺癌管理的综合公共卫生战略的需要.
相关概念视频
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

